Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell linesNannan Guo, Wen Zhang, Shaojun Li et al.|Anti-Cancer Drugs|2022Cited by 3
Development of a SciFi-based beam monitor for COMETYu Xu, Kou Oishi, C. Q. Feng et al.|arXiv (Cornell University)|2023Cited by 0